Boston, Massachusetts
United States
46
2025-09-18
The entities that hold a legal rights for patent applications filed by inventor Seed Brian:
Brian Seed from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:
INTERFERON FOR THE TREATMENT OF BRACHYURY-ASSOCIATED CANCERS AND NEOPLASMS
#2 | 2025-07-31COMPOUND FOR THE MANAGEMENT OF FELINE DIABETES
#3 | 2024-05-02PHARMACEUTICAL FORMULATIONS
#4 | 2024-01-25METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF
#5 | 2023-11-23VETERINARY PHARMACEUTICAL FORMULATIONS
#6 | 2023-09-28Antibody Derivatives with Conditionally Enabled Effector Function
#7 | 2023-01-05SODIUM-GLUCOSE LINKED TRANSPORTER INHIBITORS FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE, HYPERTENSION, AND HEART FAILURE IN COMPANION ANIMALS
#8 | 2022-04-21PHARMACEUTICAL FORMULATIONS
#9 | 2020-11-12METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF
#10 | 2020-09-17Compound for the management of feline diabetes
#11 | 2020-07-30Crystalline form of benzylbenzene SGLT2 inhibitor
#12 | 2019-11-14METHODS OF TREATING HYPERTENSION
#13 | 2018-08-02Antibody derivatives with conditionally enabled effector function
#14 | 2018-05-03Crystalline form of benzylbenzene SGLT2 inhibitor
#15 | 2016-07-21Process for the preparation of benzylbenzene SGLT2 inhibitors
#16 | 2015-09-24Crystalline form of benzylbenzene SGLT2 inhibitor
#17 | 2014-04-24Engineered thioredoxin-like fold proteins
#18 | 2014-01-30Benzylbenzene derivatives and methods of use
#19 | 2014-01-09Crystalline form of benzylbenzene SGLT2 inhibitor
#20 | 2013-10-10Process for the preparation of benzylbenzene SGLT2 inhibitors
#21 | 2012-12-27Benzylbenzene derivatives and methods of use
#22 | 2012-09-20CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR
#23 | 2011-12-22Combination therapy for the treatment of diabetes
#24 | 2011-08-25Benzylbenzene derivatives and methods of use
#25 | 2011-08-11Treating psychological conditions using muscarinic receptor Mantagonists
#26 | 2011-03-31THERAPEUTIC USES OF SGLT2 INHIBITORS
#27 | 2011-03-10Engineered transglutaminase barrel proteins
#28 | 2011-01-27INHIBITING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
#29 | 2010-10-07Fusion proteins comprising a fragment of exotoxin A
#30 | 2010-08-26PDZ DOMAIN INTERACTIONS AND LIPID RAFTS
#31 | 2010-03-11Deuterated benzylbenzene derivatives and methods of use
#32 | 2010-03-04Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
#33 | 2009-05-07Benzylbenzene derivatives and methods of use
#34 | 2008-07-15Nucleic acids encoding artificial P-selectin ligands
#35 | 2008-07-10PDZ DOMAIN INTERACTIONS AND LIPID RAFTS
#36 | 2008-01-22Redirection of cellular immunity by protein tyrosine kinase chimeras
#37 | 2007-12-20Treating obesity with muscarinic receptor Mantagonists
#38 | 2007-12-20Treating psychological conditions using muscarinic receptor Mantagonists
#39 | 2007-08-07Immunoglobulin fusion proteins, their production and use
#40 | 2006-10-10Rapid immunoselection cloning method
#41 | 2006-09-19Methods and compositions for the rapid and enduring relief of inadequate myocardial function
#42 | 2006-08-22Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
#43 | 2006-05-23Redirection of cellular immunity by receptor chimeras
#44 | 2006-04-27Methods for the production of cells and mammals with desired genetic modifications
#45 | 2005-06-30Native immunoglobulin binding reagents and methods for making and using same
#46 | 2005-03-24Antigen presenting vesicles
478560 ⎘